Home | Publications | Country | Europe (West) | Germany place holder
place holder place holder

Germany

NRT Smoking Cessation Aids in Germany


Publication Date   June 2006
Publisher   Euromonitor International
Product Type   Report
Pages   48
ISBN Number   not applicable
Product Code   EUR588
Ask a question about this product?

Price £450.00

approximately: $841 | €571

Summary


Smoking Cessation Aids in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage:

NRT gum, NRT patches, NRT inhalators, other

Data coverage:

market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

  • Get a detailed picture of the smoking cessation aids industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Content


NRT Smoking Cessation Aids in Germany

1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT

2.1 OTC Registration and Classification
2.2 Vitamins and Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 Delisting or De-reimbursement
2.7 Traditional Remedies
2.8 Homoeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005

3. OTC HEALTHCARE SALES

3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.5 Leading Company Profile - Aventis Pharma Deutschland GmbH (Nattermann & Cie GmbH)
Summary 2 Sanofi Aventis: Operational Indicators 2005
Table 7 Ratiopharm GmbH & Co: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.6 Leading Company Profile - Bayer Group (Bayer Vital GmbH)
Summary 3 Bayer Group: Operational Indicators 2005
Table 8 Bayer Vital GmbH: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.7 Leading Company Profile - Beiersdorf AG
Summary 4 Beiersdorf AG Operational Indicators 2005
Table 9 Beiersdorf AG: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.8 Leading Company Profile - Boehringer Ingelheim Pharma GmbH & Co KG
Summary 5 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators 2004
Table 10 Boehringer Ingelheim Pharma GmbH & Co KG: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.9 Leading Company Profile - GlaxoSmithKline GmbH & Co KG
Summary 6 GlaxoSmithKline Operational Indicators 2004
Table 11 GlaxoSmithKline GmbH & Co KG: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.10 Leading Company Profile - Johnson & Johnson GmbH
Summary 7 Johnson & Johnson Inc: Operational Indicators 2005
3.11 Leading Company Profile - Merck KGaA
Summary 8 Merck KGaA: Operational Indicators 2005
Table 12 Merck KGaA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.12 Leading Company Profile - Novartis Consumer Health GmbH
Summary 9 Novartis Consumer Health GmbH: Operational Indicators 2004
Table 13 Novartis Consumer Health GmbH: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.13 Leading Company Profile - Procter & Gamble GmbH
Summary 10 Procter & Gamble Operational Indicators 2005
Table 14 Procter & Gamble GmbH: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.14 Leading Company Profile - Ratiopharm GmbH & Co
Summary 11 Ratiopharm GmbH & Co: Operational Indicators 2005
Table 15 Ratiopharm GmbH & Co: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.15 Leading Company Profile - Stada Arzneimittel AG
Summary 12 Stada Arzneimittel AG: Operational Indicators 2005
Table 16 Stada Arzneimittel AG: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.16 Leading Company Profile - Viatris GmbH & Co KG (formerly known as Asta Medica AG)
Summary 13 Viatris GmbH Operational Indicators 2002
Table 17 Viatris GmbH & Co KG: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.17 Emerging and Niche Companies
3.18 Retail Distribution
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.19 Retailer Activity and Private Label Trends
Table 20 Penetration of Private Label by Sector 2001-2005
3.20 Forecast Market Performance
Table 21 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 22 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010

4. NRT SMOKING CESSATION AIDS SALES

4.1 Number of Smokers
Table 23 Number of Smokers by Gender 1998-2003
4.2 Sector Performance
Table 24 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 25 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 26 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 27 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Table 28 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 29 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
4.3 New Product Developments

5. DEFINITIONS